NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
Authors:
- 27 August 2013
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 170 (2) , 426-439
Abstract
Background and Purpose: Podocyte injury plays a key role in the development of diabetic nephropathy (DN). We have recently shown that 11R‐VIVIT, an inhibitor of cell‐permeable nuclear factor of activated T‐cells (NFAT), attenuates podocyte apoptosis induced by high glucose in vitro. However, it is not known whether 11R‐VIVIT has a protective effect on DN, especially podocyte injury, under in vivo diabetic conditions. Hence, we examined the renoprotective effects of 11R‐VIVIT in diabetic db/db mice and the possible mechanisms underlying its protective effects on podocyte injury in vivo and in vitro.Experimental Approach: Type 2 diabetic db/db mice received i.p. injections of 11R‐VIVIT (1 mg·kg−1) three times a week and were killed after 8 weeks. Immortalized mouse podocytes were cultured under different experimental conditions.Key Results: 11R‐VIVIT treatment markedly attenuated the albuminuria in diabetic db/db mice and also alleviated mesangial matrix expansion and podocyte injury. However, body weight, food and water intake, and glucose levels were unaffected. It also attenuated the increased NFAT2 activation and enhanced urokinase‐type plasminogen activator receptor (uPA receptor) expression in glomerulor podocytes. In cultured podocytes, the increased nuclear accumulation of NFAT2 and uPA receptor expression induced by high glucose treatment was prevented by 11R‐VIVIT or NFAT2‐knockdown; this was accompanied by improvements in the filtration barrier function of the podocyte monolayer.Conclusions and Implications: The NFAT inhibitor 11R‐VIVIT might be a useful therapeutic strategy for protecting podocytes and treating DN. The calcinerin/NFAT2/uPA receptor signalling pathway should be exploited as a therapeutic target for protecting podocytes from injury in DN.Keywords
This publication has 43 references indexed in Scilit:
- Genipin Inhibits Mitochondrial Uncoupling Protein 2 Expression and Ameliorates Podocyte Injury in Diabetic MicePLOS ONE, 2012
- Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes MellitusArchives of internal medicine (1960), 2012
- Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysisDiabetologia, 2011
- Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an NFAT-Mediated Positive Feedback Signaling PathwayThe American Journal of Pathology, 2011
- Calcineurin (CN) Activation Promotes Apoptosis of Glomerular Podocytes Both in Vitro and in VivoMolecular Endocrinology, 2011
- The targeted podocyteJournal of Clinical Investigation, 2011
- Activation of a nuclear factor of activated T‐lymphocyte‐3 (NFAT3) by oxidative stress in carboplatin‐mediated renal apoptosisBritish Journal of Pharmacology, 2010
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcriptionAmerican Journal of Physiology-Cell Physiology, 2009